Binding of toremifene to human serum proteins. 1988

H Sipilä, and V Näntö, and L Kangas, and M Anttila, and T Halme
Farmos Group Ltd., Research Center, Turku, Finland.

The in vitro protein binding of toremifene in human serum was measured by ultracentrifugation using 3H-toremifene together with unlabeled toremifene, 50, 500, and 5000 ng/ml. Of the total radioactivity 99.7 per cent was bound to the proteins independent of the concentration of the unlabeled drug. Binding of toremifene to different protein fractions was studied by adding 3H-toremifene and 500 ng/ml of cold toremifene to normal serum. The serum samples were exposed to agarose gel electrophoresis to fractionate different proteins. The radioactivity was localized using a position-sensitive proportional counter. After that the proteins were visualized by staining. Of the total protein bound radioactivity 92 per cent was bound to albumin, about 6 per cent to beta 1 globulin fraction and about 2 per cent to a fraction between albumin and alpha 1 globulins, part of this probably to alpha 1 acid glycoprotein.

UI MeSH Term Description Entries
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013629 Tamoxifen One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM. ICI-46,474,ICI-46474,ICI-47699,Nolvadex,Novaldex,Soltamox,Tamoxifen Citrate,Tomaxithen,Zitazonium,Citrate, Tamoxifen,ICI 46,474,ICI 46474,ICI 47699,ICI46,474,ICI46474,ICI47699
D017312 Toremifene A first generation selective estrogen receptor modulator (SERM). Like TAMOXIFEN, it is an estrogen agonist for bone tissue and cholesterol metabolism but is antagonistic on mammary and uterine tissue. FC-1157a,Fareston,Toremifene Citrate,Toremifene Citrate (1:1),Toremifene, (E)-Isomer,Citrate, Toremifene,FC 1157a,FC1157a

Related Publications

H Sipilä, and V Näntö, and L Kangas, and M Anttila, and T Halme
January 1987, European journal of clinical pharmacology,
H Sipilä, and V Näntö, and L Kangas, and M Anttila, and T Halme
June 1984, The Journal of pharmacy and pharmacology,
H Sipilä, and V Näntö, and L Kangas, and M Anttila, and T Halme
February 1978, Toxicology and applied pharmacology,
H Sipilä, and V Näntö, and L Kangas, and M Anttila, and T Halme
January 1963, Scandinavian journal of clinical and laboratory investigation,
H Sipilä, and V Näntö, and L Kangas, and M Anttila, and T Halme
November 1981, Journal of pharmaceutical sciences,
H Sipilä, and V Näntö, and L Kangas, and M Anttila, and T Halme
January 1976, Ceskoslovenska fysiologie,
H Sipilä, and V Näntö, and L Kangas, and M Anttila, and T Halme
March 1975, Biochemical pharmacology,
H Sipilä, and V Näntö, and L Kangas, and M Anttila, and T Halme
January 1982, Acta radiologica: diagnosis,
H Sipilä, and V Näntö, and L Kangas, and M Anttila, and T Halme
March 1974, Experientia,
H Sipilä, and V Näntö, and L Kangas, and M Anttila, and T Halme
March 1994, Journal of environmental science and health. Part. B, Pesticides, food contaminants, and agricultural wastes,
Copied contents to your clipboard!